Analysis reveals advancements in anal fistula treatment for Crohn’s disease

A bibliometric study of 1,608 articles from 1994 to 2024 highlights the evolving landscape of anal fistula treatment in Crohn’s disease. Researchers identified significant contributions from 325 countries, with the US and UK leading in publication volume. The Cleveland Clinic and Imperial College London emerged as influential institutions. Trends show a focus on surgical interventions, biologic therapies, and imaging modalities. Findings emphasize the need for standardized treatments and comprehensive clinical trials to enhance care for Crohn’s disease patients.